Cargando…

The therapeutic potential for targeting CSE/H(2)S signaling in macrophages against Escherichia coli infection

Macrophages play a pivotal role in the inflammatory response to the zoonotic pathogen E. coli, responsible for causing enteric infections. While considerable research has been conducted to comprehend the pathogenesis of this disease, scant attention devoted to host-derived H(2)S. Herein, we reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Shaodong, Wang, Zhenglei, Han, Xiangan, Xu, Yuanyuan, Miao, Jinfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466716/
https://www.ncbi.nlm.nih.gov/pubmed/37644526
http://dx.doi.org/10.1186/s13567-023-01203-8
_version_ 1785098949896437760
author Fu, Shaodong
Wang, Zhenglei
Han, Xiangan
Xu, Yuanyuan
Miao, Jinfeng
author_facet Fu, Shaodong
Wang, Zhenglei
Han, Xiangan
Xu, Yuanyuan
Miao, Jinfeng
author_sort Fu, Shaodong
collection PubMed
description Macrophages play a pivotal role in the inflammatory response to the zoonotic pathogen E. coli, responsible for causing enteric infections. While considerable research has been conducted to comprehend the pathogenesis of this disease, scant attention devoted to host-derived H(2)S. Herein, we reported that E. coli infection enhanced the expression of CSE in macrophages, accompanied by a significantly increased inflammatory response. This process may be mediated by the involvement of excessive autophagy. Inhibition of AMPK or autophagy with pharmacological inhibitors could alleviate the inflammation. Additionally, cell model showed that the mRNA expression of classic inflammatory factors (Il-1β, Il-6), macrophage polarization markers (iNOS, Arg1) and ROS production was significantly down-regulated after employing CSE specific inhibitor PAG. And PAG is capable of inhibiting excessive autophagy through the LKB1-AMPK-ULK1 axis. Interestingly, exogenous H(2)S could suppress inflammation response. Our study emphasizes the importance of CSE in regulating the macrophage-mediated response to E. coli. Increased CSE in macrophages leads to excessive inflammation, which should be considered a new target for drug development to treat intestinal infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13567-023-01203-8.
format Online
Article
Text
id pubmed-10466716
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104667162023-08-31 The therapeutic potential for targeting CSE/H(2)S signaling in macrophages against Escherichia coli infection Fu, Shaodong Wang, Zhenglei Han, Xiangan Xu, Yuanyuan Miao, Jinfeng Vet Res Research Article Macrophages play a pivotal role in the inflammatory response to the zoonotic pathogen E. coli, responsible for causing enteric infections. While considerable research has been conducted to comprehend the pathogenesis of this disease, scant attention devoted to host-derived H(2)S. Herein, we reported that E. coli infection enhanced the expression of CSE in macrophages, accompanied by a significantly increased inflammatory response. This process may be mediated by the involvement of excessive autophagy. Inhibition of AMPK or autophagy with pharmacological inhibitors could alleviate the inflammation. Additionally, cell model showed that the mRNA expression of classic inflammatory factors (Il-1β, Il-6), macrophage polarization markers (iNOS, Arg1) and ROS production was significantly down-regulated after employing CSE specific inhibitor PAG. And PAG is capable of inhibiting excessive autophagy through the LKB1-AMPK-ULK1 axis. Interestingly, exogenous H(2)S could suppress inflammation response. Our study emphasizes the importance of CSE in regulating the macrophage-mediated response to E. coli. Increased CSE in macrophages leads to excessive inflammation, which should be considered a new target for drug development to treat intestinal infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13567-023-01203-8. BioMed Central 2023-08-29 2023 /pmc/articles/PMC10466716/ /pubmed/37644526 http://dx.doi.org/10.1186/s13567-023-01203-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Fu, Shaodong
Wang, Zhenglei
Han, Xiangan
Xu, Yuanyuan
Miao, Jinfeng
The therapeutic potential for targeting CSE/H(2)S signaling in macrophages against Escherichia coli infection
title The therapeutic potential for targeting CSE/H(2)S signaling in macrophages against Escherichia coli infection
title_full The therapeutic potential for targeting CSE/H(2)S signaling in macrophages against Escherichia coli infection
title_fullStr The therapeutic potential for targeting CSE/H(2)S signaling in macrophages against Escherichia coli infection
title_full_unstemmed The therapeutic potential for targeting CSE/H(2)S signaling in macrophages against Escherichia coli infection
title_short The therapeutic potential for targeting CSE/H(2)S signaling in macrophages against Escherichia coli infection
title_sort therapeutic potential for targeting cse/h(2)s signaling in macrophages against escherichia coli infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466716/
https://www.ncbi.nlm.nih.gov/pubmed/37644526
http://dx.doi.org/10.1186/s13567-023-01203-8
work_keys_str_mv AT fushaodong thetherapeuticpotentialfortargetingcseh2ssignalinginmacrophagesagainstescherichiacoliinfection
AT wangzhenglei thetherapeuticpotentialfortargetingcseh2ssignalinginmacrophagesagainstescherichiacoliinfection
AT hanxiangan thetherapeuticpotentialfortargetingcseh2ssignalinginmacrophagesagainstescherichiacoliinfection
AT xuyuanyuan thetherapeuticpotentialfortargetingcseh2ssignalinginmacrophagesagainstescherichiacoliinfection
AT miaojinfeng thetherapeuticpotentialfortargetingcseh2ssignalinginmacrophagesagainstescherichiacoliinfection
AT fushaodong therapeuticpotentialfortargetingcseh2ssignalinginmacrophagesagainstescherichiacoliinfection
AT wangzhenglei therapeuticpotentialfortargetingcseh2ssignalinginmacrophagesagainstescherichiacoliinfection
AT hanxiangan therapeuticpotentialfortargetingcseh2ssignalinginmacrophagesagainstescherichiacoliinfection
AT xuyuanyuan therapeuticpotentialfortargetingcseh2ssignalinginmacrophagesagainstescherichiacoliinfection
AT miaojinfeng therapeuticpotentialfortargetingcseh2ssignalinginmacrophagesagainstescherichiacoliinfection